Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Hepatoblastoma: Experience of the paediatric haematology and oncology department, Hassan II university hospital of Fez.

Breadcrumb

  • Home
  • Hepatoblastoma: Experience of the paediatric haematology and oncology department, Hassan II university hospital of Fez.

V. KASHAMA *, G. OVIEBO ANDO, S. BOURAMDANE, K. ELMKADDEM, H. HBIBI and S. BENMILOUD.

Department of paediatrics, Hassan II University Hospital, University Sidi Mohammed Ben Abdellah, Fez, Morocco.
 
Case Study
World Journal of Advanced Research and Reviews, 2024, 22(02), 185-189
Article DOI: 10.30574/wjarr.2024.22.2.1363
DOI url: https://doi.org/10.30574/wjarr.2024.22.2.1363
 
Received on 16 March 2024; revised on 01 May 2024; accepted on 03 May 2024
 
Introduction: Hepatoblastoma is the most common malignant hepatic tumour in children. However, it is a rare disease, representing approximately 2% of childhood tumours. The treatment combines chemotherapy with surgical excision. The objective of this study was to describe the epidemiological, clinical, therapeutic and progressive aspects of hepatoblastoma treated in the paediatric haematology and oncology department at the University Hospital Hassan II of Fès.
Patients and Methods: This was a descriptive and retrospective study conducted over a 11-year period. All patients aged 0 to 15 years who were admitted and treated for hepatoblastoma were included.
Results: 24 patients met the study criteria, including 9 boys and 15 girls. The average age at diagnosis was 11.52 months ± 4.9. The most common reason for consultation was abdominal distension. Hepatomegaly was observed in 50% of cases. The average tumour size was 116 mm. At the time of diagnosis, one-third of patients had pulmonary metastases, and all patients were classified as high risk. Therapeutically, 19 patients (79.17%) received chemotherapy and 16 (66.67%) underwent surgery. On the evolutionary level, we observed a recovery without events in 10 (41.67%) patients.
Conclusion: hepatoblastoma is a rare tumour, but remains the most common hepatic tumour in children. Despite progress in diagnostic and therapeutic means, the mortality rate is significant.
 
Hepatoblastoma; Alpha Foeto-Protein; Chemotherapy; Hepatectomy.
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2024-1363.pdf

Preview Article PDF

V. KASHAMA, G. OVIEBO ANDO, S. BOURAMDANE, K. ELMKADDEM, H. HBIBI and S. BENMILOUD. Hepatoblastoma: Experience of the paediatric haematology and oncology department, Hassan II university hospital of Fez.. World Journal of Advanced Research and Reviews, 2024, 22(2), 185-189. Article DOI: https://doi.org/10.30574/wjarr.2024.22.2.1363

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution